GlassScriptPhysician profile
Vinay Chopra
NPI 1730329079
$2,512.46
in general payments reported to CMS, 2019-2025
13 companies · $65.38 in 2025
The $65.38 reported for 2025 was less than what a typical Sports Medicine (Family Medicine) provider received nationally (typical 2025 total: $113).
See the full distribution for Sports Medicine (Family Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $92.31 · 2020: $1,693 · 2021: $247 · 2022: $154 · 2023: $177 · 2024: $82.93 · 2025: $65.38.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $325.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $325.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hydrocision, INC. | $1,650.00 | 2020 | |
| Nuvasive, INC. | $380.54 | 2021-2023 | Acp |
| Depuy Synthes Sales INC. | $136.60 | 2019-2025 | Orthovisc |
| Trice Medical, INC. | $133.23 | 2022 | |
| Bioventus LLC | $47.38 | 2020-2024 | Durolane |
| International Rehabilitative Sciences, INC | $34.65 | 2024 | Rs 4i Plus Sequential Stimulator |
| Ossur Americas, INC. | $24.16 | 2025 | Unloader One X |
| Allergan, INC. | $23.02 | 2020 | |
| Avanos Medical | $21.12 | 2022 | |
| Medacta USA, INC. | $18.22 | 2025 | Primary Shoulder |
| Convatec INC. | $16.15 | 2023 | |
| Pfizer INC. | $14.13 | 2021 | |
| Ibsa Pharma INC. | $13.26 | 2023 | Tirosint, Licart |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vinay Chopra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.